NCT02202980
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- Auckland, New Zealand
- Christchurch, New Zealand
Clinical trial condition
Hepatitis, Chronic
Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.
1,281 public trials
89 recruiting studies
Hepatitis, Chronic trial results
NCT02487030
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
- Al Mansurah, Egypt
- Cairo, Egypt
- Cairo, Egypt
- Shibīn al Kawm, Egypt
NCT01826981
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- Auckland Clinical Studies Ltd. Auckland, New Zealand
- Christchurch Clinical Studies Trust Christchurch, New Zealand
Completed
Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects
NCT01726517
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
- Locations
-
- San Antonio, Texas, United States
NCT02413593
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
- Calgary, Alberta, Canada
- Edmonton, Alberta, Canada
- Edmonton, Alberta, Canada
- Vancouver, British Columbia, Canada
NCT02472886
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
- Tallinn, Estonia
- Tartu, Estonia
- Krasnoyarsk, Russia
- Moscow, Russia
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
- Locations
-
Not specified
NCT01379508
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Novartis Investigative Site Innsbruck, Austria
- Novartis Investigative Site Vienna, Austria
- Novartis Investigative Site Sofia, Bulgaria
- Novartis Investigative Site Sofia, Bulgaria
NCT01548690
- Conditions
- Acute Liver Failure, Acute Liver Injury, Autoimmune Diseases, +21 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Yale University School of Medicine New Haven, Connecticut, United States
- Emory University Atlanta, Georgia, United States
- Northwestern University Chicago, Illinois, United States
Completed
Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
NCT02597166
- Conditions
- Blood-Borne Infections, Chronic Disease, Cirrhosis, Decompensated, +16 more
- Locations
-
- University Health Network - Toronto General Hospital Toronto, Ontario, Canada